BPM
ARNA

Bowling Portfolio Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bowling Portfolio Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,334
Closed -$696K – 404
2019
Q4 		$696K Sell
15,334
-6,072
-28% -$287K 0.12% 256
2019
Q3 		$980K Buy
+21,406
New +$1.2M 0.16% 223

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bowling Portfolio Management's ARNA Position: Q1 2020 in Review

Bowling Portfolio Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 15,334 shares — an estimated $696K sold.

Bowling Portfolio Management first reported a position in ARNA in Q3 2019 and held it in 2 quarters. The position peaked at $980K in Q3 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • Bowling Portfolio Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Bowling Portfolio Management sold 15,334 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $696K.
  • Bowling Portfolio Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 2 quarters.
  • Bowling Portfolio Management's Arena Pharmaceuticals Inc position peaked at $980K in Q3 2019.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Bowling Portfolio Management's 13F filing for Q1 2020, filed 5 May 2020.